… arterial disease (PAD) afflicts up to 20% of older people and is associated with a high risk of
cardiovascular (CV) morbidity, but a rather low risk of progression … and disease progression. …

… disease progression was defined as any increase in SSS from baseline to follow-up CCTA.
Conversely, regression … were excluded from disease progression or regression calculations. …

… This study included 605 patients with coronary artery disease (CAD). Two coronary
angiographic examinations at baseline and after 2 years were performed. The analysis focused on …

… artery (ICA) progression. This study assessed ipsilateral and contralateral disease progression
… Survival analysis and Cox regression models were used to assess the effect of baseline …

… When it comes to treating coronary artery disease (CAD), and identifying coronary …
effect of medical therapies on coronary plaque progression, regression, and stabilization. …

… Therefore, statin may stabilize coronary artery disease through its dual actions on plaque
morphology, that is, regression of atheroma and increment of calcified deposit. The stimulatory …

… To determine progression or regression of coronary artery atherosclerosis, annual change
in PB (△PB/y, %/y) was defined as follows: ([△PB]/[interval between CCTA examinations (…

… that showed regression of SVD markers. Here, we provide a review on disease progression
in sporadic SVD, thereby taking into account both progression and regression of SVD …

… surrogate markers of coronary artery disease in lieu of coronary artery disease itself, our
proposed approach to targeting atherosclerosis as the primary disease target is intuitive but …

… The aim of the study is examine the impact of non-obstructive (<50%stenosis) left main (LM)
disease on the natural history of coronary artery disease using serial coronary computed …